Stock Groups

Ocugen Surges on Claim Covid Vaccine May Protect Against Variants -Breaking

by Mike Robinson

[ad_1]

© Reuters

By Dhirendra Tripathi

Investing.com – Ocugen stock (NASDAQ:) climbed 7% in Wednesday’s premarket trading after the company said it has data suggesting its Covid-19 vaccine could provide protection against both current and future variants of the virus.

Company said that it was currently reviewing the vaccine Covaxin for Omicron variants and intends to share all data once they are ready.

Omicron, which is “of concern” according to the World Health Organization has been identified in over 60 countries. It now outnumbers Delta in many countries. Omicron is believed to have spread faster than Delta and has caused countries in Australia and Europe to impose restrictions on the movement of business and people.   

Ocugen claimed that the vaccine produced a solid immune memory to the virus, and the protection lasted at most 6 months.

Covaxin has been developed by India’s Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Ocugen co-developed Covaxin in partnership with Bharat Biotech. The vaccine will be available for sale in Canada and the United States once regulatory approval is granted. 

Covaxin, India’s second most-used vaccine is one of the worst hit countries by the pandemic. 

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]